Efficacy of SGLT2 Inhibitors Versus Pioglitazone in the Treatment of Non-alcoholic Fatty Liver Disease or Non-alcoholic Steatohepatitis: A Systematic Review

Non-alcoholic fatty liver disease (NAFLD) is a complication related to obesity and metabolic syndrome. There are increased incidences of NAFLD/non-alcoholic steatohepatitis (NASH) due to rising obesity and type 2 diabetes mellitus (T2DM). This has resulted in significant morbidity and mortality. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaur, Simran, Sojitra, Vani, Zahra, Anam, Hutchinson, Jhenelle, Folawemi, Oluwa, Bittla, Parikshit, Ramphall, Shivana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516583/
https://www.ncbi.nlm.nih.gov/pubmed/37745748
http://dx.doi.org/10.7759/cureus.45789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516583/
https://www.ncbi.nlm.nih.gov/pubmed/37745748
http://dx.doi.org/10.7759/cureus.45789

Ejemplares similares